儿童癫痫何时开始药物治疗:临床流行病学证据

When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.

作者信息

Arts Willem F M, Geerts Ada T

机构信息

Department of Paediatric Neurology, Erasmus Medical Center, Sophia Children's Hospital, P.O. Box 2060, 3000 CB Rotterdam, The Netherlands.

出版信息

Eur J Paediatr Neurol. 2009 Mar;13(2):93-101. doi: 10.1016/j.ejpn.2008.02.010. Epub 2008 Jun 24.

Abstract

INTRODUCTION

Many data on the course and prognosis after provoked and unprovoked single and multiple seizures in childhood have been collected in the past decennia by prospective, large-scale, long-term observational cohort studies. These data may serve to guide treatment decisions and help to design controlled trials investigating treatment strategies in childhood epilepsy.

METHODS

The results of the Dutch study of epilepsy in childhood will be compared with those of other studies. We will also discuss the potential consequences of these results for the "why" and "when" of the decision to start treatment.

RESULTS

Recurrence after a solitary unprovoked seizure in childhood is about 50%. Those with a recurrence have a similar outcome of their epilepsy compared to children presenting with multiple seizures, regardless whether they were treated after the first seizure or not. This argues in favour of postponing anti-epileptic drug (AED) treatment until at least a second seizure has occurred. After an unprovoked status epilepticus (SE), later outcome is not worse than after presentation with a short seizure. Therefore, long-term AED treatment after a single unprovoked SE may not be necessary either. The same holds true for children presenting with a short (less than one week) burst of unprovoked seizures. One quarter of them do not have recurrences and the final prognosis of children with recurrences does again not differ from the prognosis of the entire cohort. Findings in new-onset epilepsy further indicate that AED treatment can be safely omitted or at least postponed in about 15%, especially those with only a small number of seizures before presentation, those with benign partial epilepsy and those with sporadic generalised tonic-clonic seizures. On the reverse side, three considerations might lead to the decision to start early and aggressive treatment: the dangers of the seizures, the chance of intractability and the possibility of intellectual decline caused by recurrent seizures or epileptic activity. In idiopathic generalised absence epilepsy, the risks of accidents and learning problems indeed prompt early AED treatment. A self-propagating mechanism of seizures promoting the occurrence of more seizures, in the end causing intractable epilepsy (Gowers), occurs only rarely. Real intractability is seen in only 5-15% of the children with new-onset epilepsy. The chance of intractability is increased by variables like symptomatic aetiology, localisation-related epilepsy, and an early unfavourable course. Landau-Kleffner or continuous spikes and waves during sleep (CSWS) syndrome cause cognitive decline and syndromes like West, Lennox-Gastaut or Dravet's induce both psychomotor regression and intractability. In such cases, early aggressive treatment is indicated, including early consideration of the ketogenic diet, immunotherapy, vagus nerve stimulation and, if possible, referral for epilepsy surgery.

CONCLUSIONS

Omitting or postponing treatment after a solitary seizure, an unprovoked SE, a single burst of seizures or multiple infrequent seizures usually does not worsen the prognosis. A poor prognosis and the consequent indication for early and aggressive treatment are dependent mainly upon the presence of variables like symptomatic aetiology, certain epilepsy types and syndromes, and the early evolution of the epilepsy in that particular child. Intellectual decline caused by seizures or epilepsy is rare and may be confined to certain specific and readily recognizable syndromes.

摘要

引言

在过去十年中,通过前瞻性、大规模、长期观察性队列研究收集了许多关于儿童诱发性和非诱发性单次及多次癫痫发作后的病程和预后的数据。这些数据可用于指导治疗决策,并有助于设计研究儿童癫痫治疗策略的对照试验。

方法

将荷兰儿童癫痫研究的结果与其他研究的结果进行比较。我们还将讨论这些结果对于决定开始治疗的“原因”和“时机”的潜在影响。

结果

儿童单次非诱发性癫痫发作后的复发率约为50%。复发者的癫痫预后与多次发作的儿童相似,无论他们在首次发作后是否接受治疗。这支持将抗癫痫药物(AED)治疗推迟到至少第二次发作后。在非诱发性癫痫持续状态(SE)后,后期预后并不比短暂发作后更差。因此,单次非诱发性SE后长期使用AED治疗可能也没有必要。对于短暂(少于一周)的非诱发性癫痫发作群的儿童也是如此。其中四分之一不会复发,复发儿童的最终预后与整个队列的预后也没有差异。新发癫痫的研究结果进一步表明,约15%的患者可以安全地省略或至少推迟AED治疗,特别是那些在发作前只有少量发作、患有良性部分性癫痫和散发性全身强直阵挛性发作的患者。另一方面,有三个因素可能导致决定早期积极治疗:癫痫发作的危险性、难治性的可能性以及反复癫痫发作或癫痫活动导致智力下降的可能性。在特发性全身性失神癫痫中,事故和学习问题的风险确实促使早期AED治疗。癫痫发作的自我传播机制促进更多癫痫发作的发生,最终导致难治性癫痫(高尔斯),这种情况很少见。在新发癫痫儿童中,只有5-15%会出现真正的难治性。症状性病因、定位相关癫痫和早期不良病程等变量会增加难治性的可能性。Landau-Kleffner综合征或睡眠期持续棘慢波(CSWS)综合征会导致认知下降,而West综合征、Lennox-Gastaut综合征或Dravet综合征等会导致精神运动发育倒退和难治性。在这种情况下,需要早期积极治疗,包括早期考虑生酮饮食、免疫治疗、迷走神经刺激,如有可能,转诊进行癫痫手术。

结论

在单次发作、非诱发性SE、单次癫痫发作群或多次偶发性发作后省略或推迟治疗通常不会使预后恶化。预后不良以及因此而进行早期积极治疗的指征主要取决于症状性病因、某些癫痫类型和综合征以及该特定儿童癫痫的早期演变等变量。癫痫发作或癫痫导致的智力下降很少见,可能仅限于某些特定且易于识别的综合征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索